Sumatriptan
Product Images NDC 50436-4623

4 FDA label images from Unit Dose Services · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 50436-4623). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A line graph showing the estimated probability of response over time in minutes from the initial dose, comparing placebo and three different doses (25 mg, 50 mg, 100 mg) of sumatriptan. The vertical axis represents the probability of response as a percentage, while the horizontal axis shows time up to 240 minutes. Higher doses generally show higher response probabilities over time compared to placebo.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
A line graph depicting the estimated probability of remediation or rescue over 24 hours from the initial dose for different doses of SUMATRIPTAN (25 mg, 50 mg, 100 mg) compared to placebo. The y-axis represents probability percentages from 0% to 100%, and the x-axis shows time in hours. Four lines illustrate the response rates for placebo and each dose level over time.*
FDA Label Image

Label Image (Lbl504364623)

Label Image (Lbl504364623)
Label for SUMATRIPTAN SUCCINATE 50 MG tablets by Unit Dose Services, showing the NDC 50436-4623, package quantity of 9 tablets. The label includes storage instructions to keep the medication out of reach of children, at controlled room temperature, and has placeholders for manufacturing and expiration details.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of sumatriptan with structural detail of its indole and sulfonamide groups, accompanied by an additional component consistent with a fumarate salt moiety, showing carboxylic acid groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.